Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
21-Oct-2026 | 519.1 | 538.7 | 511.9 | 533.6 | 31,331 | 14,44,89,324.2 | 1,54,373 |
22-Oct-2026 | 526.45 | 535.95 | 511.6 | 530.6 | 27,732 | 15,91,81,654.2 | 1,58,522 |
23-Oct-2026 | 524 | 528.7 | 512.95 | 522.95 | 28,941 | 16,14,01,167.1 | 1,91,120 |
26-Oct-2026 | 515.55 | 534.95 | 515.55 | 530 | 11,832 | 4,03,93,075.15 | 36,208 |
27-Oct-2026 | 528.25 | 553 | 528.2 | 550.5 | 15,635 | 8,57,93,201.3 | 93,205 |
28-Oct-2026 | 552 | 563.4 | 545.2 | 551.2 | 15,785 | 11,49,90,114.45 | 97,088 |
29-Oct-2026 | 549.5 | 558 | 543.05 | 553.85 | 7,564 | 3,35,83,357.7 | 29,852 |
30-Oct-2026 | 551.2 | 556.7 | 541.15 | 545.65 | 7,444 | 2,72,37,926.3 | 23,648 |
02-Nov-2026 | 548.35 | 564.45 | 546.35 | 559.9 | 10,189 | 9,07,58,943.15 | 1,10,458 |
03-Nov-2026 | 563 | 572.25 | 549 | 568.7 | 15,628 | 14,98,96,541.85 | 1,32,337 |
04-Nov-2026 | 579 | 586 | 548.5 | 581.25 | 56,204 | 61,62,14,711.95 | 3,72,269 |
05-Nov-2026 | 591 | 591 | 563.75 | 571 | 26,391 | 15,31,44,041.4 | 1,47,614 |
06-Nov-2026 | 570 | 573.6 | 565.1 | 568.75 | 23,098 | 11,44,60,646.1 | 1,39,918 |
08-Nov-2026 | 575.5 | 580 | 574.35 | 576.9 | 1,383 | 1,37,02,011.75 | 13,754 |
09-Nov-2026 | 578.5 | 587 | 570.5 | 582.35 | 13,520 | 9,10,21,220.8 | 98,006 |
11-Nov-2026 | 583.55 | 585.95 | 573.1 | 576.15 | 16,639 | 6,70,57,614.15 | 58,806 |
12-Nov-2026 | 576.15 | 577.5 | 564.15 | 565.2 | 12,388 | 16,35,22,552.9 | 1,48,875 |
13-Nov-2026 | 564.5 | 580.65 | 562.7 | 564.2 | 14,575 | 11,17,80,337.05 | 95,177 |
16-Nov-2026 | 568.5 | 577.5 | 558.6 | 574.15 | 20,550 | 15,73,14,547.7 | 1,48,484 |
17-Nov-2026 | 573.05 | 576.45 | 566 | 567 | 9,415 | 4,77,85,561.75 | 45,421 |
18-Nov-2026 | 567 | 576.8 | 561.5 | 564.3 | 12,051 | 9,50,75,711.2 | 97,386 |
19-Nov-2026 | 567.1 | 574.95 | 556.85 | 558.7 | 17,812 | 10,13,68,557.7 | 1,00,051 |
Metropolis Healthcare said it plans to expand its genomic test portfolio to more than 500 advanced tests over the next two to three years
The deal includes a deferred payment of ₹1.7 crore, which will be disbursed as per the terms of the business transfer agreement, the company said in a regulatory filing.
The EBITDA margin fell to 18% in Q4 FY25 from 24.2% in Q4 FY24, reflecting a fall in operational efficiency or profitability.
The EBITDA margin was stable at 22.3% and did not change much from the year-ago period.
This is a 100% stake purchase that will be funded through 55% cash and 45% equity swap. It expects completion in 60 days, after shareholders give their nod.
Here are some of the stocks that may see significant price movement today: Tata Motors, Asian Paints, Divi’s Laboratories, etc.
Here are some of the stocks that may see significant price movement today: Titan Company, HDFC Bank, IndusInd Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.